Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Liraglutide (Saxenda) An older GLP-1 agonist, daily injection, less effective than semaglutide or tirzepatide but still TGA approved for weight management
Start with conservative protocols and monitor for any adverse effects
Novo Nordisk has launched its own telehealth programme for regular-dose semaglutide through its own channels, as well as other providers, for $499 per month, although a partnership with Hims & Hers quickly broke down due to what the company said were "concerns about [] illegal mass compounding and deceptive marketing." Hims & Hers which accused Novo Nordisk of 'anticompetitive' actions is now offering a compounded version at $199 per month.
This research peptide is not intended for human consumption, veterinary use, diagnostic procedures, therapeutic applications, cosmetic use, or medical treatment
This versatility allows distributors to offer products that meet regional consumer preferences and drive faster adoption
Fitness People on GLP1s were twice as likely to exercise (35% versus 71%) after they started taking medication
